Fosaprepitant
- Product NDC
- 68180-690
- 11-digit product format
- 681800690
- Labeler code
- 68180
- Product ID
- 68180-690_51402da2-3a88-42a0-b1ca-ce61834a8e91
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Fosaprepitant
- Dosage form
- INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
- Route
- INTRAVENOUS
- Labeler
- Lupin Pharmaceuticals, Inc.
- Application
- ANDA210689
- Marketing category
- ANDA
- Marketing start
- 2020-09-25
- Marketing end
- 0000-00-00
- Substance
- FOSAPREPITANT DIMEGLUMINE
- Active strength
- 150 mg/5mL
- Pharmacologic classes
- Cytochrome P450 2C9 Inducers [MoA], Cytochrome P450 3A4 Inducers [MoA], Cytochrome P450 3A4 Inhibitors [MoA], Neurokinin 1 Antagonists [MoA], Substance P/Neurokinin-1 Receptor Antagonist [EPC]
- NDC exclude flag
- No
- Listing certified through
- 2023-12-31
- Current FDA listing
- Historical FDA.report record
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 68180-690-01 | 68180069001 | 1 VIAL in 1 CARTON (68180-690-01) > 5 mL in 1 VIAL | 1 vial | 2020-09-25 | 0000-00-00 | No | No | Current |